← FDA Drug Approvals (Drugs@FDA)
BLEOMYCIN SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-03-11
Drug application
- FDA Application #
ANDA209439- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BLEOMYCIN SULFATE
- Generic name
- Bleomycin Sulfate
- Active ingredients
- BLEOMYCIN SULFATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- CIPLA
- First approval
- 2019-03-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown